These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18588959)

  • 1. On the incorporation of chemical-specific information in risk assessment.
    Clewell HJ; Andersen ME; Blaauboer BJ
    Toxicol Lett; 2008 Aug; 180(2):100-9. PubMed ID: 18588959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of mode of action in risk assessment: past, present, and future.
    Clewell H
    Regul Toxicol Pharmacol; 2005 Jun; 42(1):3-14. PubMed ID: 15896438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of good modelling practice for physiologically based pharmacokinetic models for use in risk assessment: the first steps.
    Loizou G; Spendiff M; Barton HA; Bessems J; Bois FY; d'Yvoire MB; Buist H; Clewell HJ; Meek B; Gundert-Remy U; Goerlitz G; Schmitt W
    Regul Toxicol Pharmacol; 2008 Apr; 50(3):400-11. PubMed ID: 18331772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and specification of physiologically based pharmacokinetic models for use in risk assessment.
    Clewell RA; Clewell HJ
    Regul Toxicol Pharmacol; 2008 Feb; 50(1):129-43. PubMed ID: 18077066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of in vitro toxicity data in hazard and risk assessment: current limitations and future perspectives.
    Blaauboer BJ
    Toxicol Lett; 2008 Aug; 180(2):81-4. PubMed ID: 18586419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative risk assessment of pesticide residues in food.
    Boobis AR; Ossendorp BC; Banasiak U; Hamey PY; Sebestyen I; Moretto A
    Toxicol Lett; 2008 Aug; 180(2):137-50. PubMed ID: 18585444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of science-based uncertainty factors in noncancer risk assessment.
    Dourson ML; Felter SP; Robinson D
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):108-20. PubMed ID: 8933624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistics for risk assessment of chemical carcinogens.
    Chen JJ; Chen YJ; Cheng KF
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(4):281-312. PubMed ID: 18000784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. History of the American College of Toxicology (ACT).
    Christian MS
    Int J Toxicol; 2004; 23(5):285-99. PubMed ID: 15513830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action as a determining factor in additivity models for chemical mixture risk assessment.
    Lambert JC; Lipscomb JC
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):183-94. PubMed ID: 17804132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciding which chemical mixtures risk assessment methods work best for what mixtures.
    Teuschler LK
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):139-47. PubMed ID: 16997340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of in vitro data in risk assessment.
    Bernauer U; Oberemm A; Madle S; Gundert-Remy U
    Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):176-81. PubMed ID: 15733212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for deriving pesticide aquatic life criteria.
    TenBrook PL; Tjeerdema RS; Hann P; Karkoski J
    Rev Environ Contam Toxicol; 2009; 199():19-109. PubMed ID: 19110939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: implications for risk assessment.
    Rietjens IM; Punt A; Schilter B; Scholz G; Delatour T; van Bladeren PJ
    Mol Nutr Food Res; 2010 Feb; 54(2):195-207. PubMed ID: 19943261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty characterization approaches for risk assessment of DBPs in drinking water: a review.
    Chowdhury S; Champagne P; McLellan PJ
    J Environ Manage; 2009 Apr; 90(5):1680-91. PubMed ID: 19167150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting interactions from mechanistic information: can omic data validate theories?
    Borgert CJ
    Toxicol Appl Pharmacol; 2007 Sep; 223(2):114-20. PubMed ID: 17306318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biokinetic and dosimetric modelling in the estimation of radiation risks from internal emitters.
    Harrison J
    J Radiol Prot; 2009 Jun; 29(2A):A81-A105. PubMed ID: 19454809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormesis: from marginalization to mainstream: a case for hormesis as the default dose-response model in risk assessment.
    Calabrese EJ
    Toxicol Appl Pharmacol; 2004 Jun; 197(2):125-36. PubMed ID: 15163548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential.
    Roberts DW; Aptula AO; Patlewicz G; Pease C
    J Appl Toxicol; 2008 May; 28(4):443-54. PubMed ID: 17703503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concepts of exposure analysis for consumer risk assessment.
    Heinemeyer G
    Exp Toxicol Pathol; 2008 Jun; 60(2-3):207-12. PubMed ID: 18424011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.